Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

NEW YORK CITY — A new study published in the July 8 issue of British Medical Journal Online First confirms previous findings that women use emergency contraception (EC) responsibly.

The study, which tracked the use of EC in Britain since it became available without a prescription in 2001, revealed that over-the-counter status does not decrease the use of regular contraceptive methods. In light of these results, Planned Parenthood Federation of America (PPFA) today again urged the FDA to grant over-the-counter status to EC.

"Access to emergency contraception is good medicine. By delaying its decision, the FDA is flunking science and failing women," said PPFA Vice President of Medical Affairs Vanessa Cullins, M.D. "Women should have over-the-counter access to EC immediately. The FDA has allowed politics to pollute the sound judgment of medical experts, and we call on them to quit stalling."

To date the FDA has ignored overwhelming evidence in support of over-the-counter status for EC and has refused to issue a ruling.

"This study proves once again that women make responsible decisions when they have access to EC," said Cullins. "There is no legitimate reason to deny access to this safe, effective backup method of contraception."

On December 16, 2003, a joint hearing of the FDA Nonprescription Drugs and Reproductive Health Drugs Advisory Committees voted 23 to 4 to recommend that the FDA make Plan B emergency contraception available over the counter. On May 6, 2004, the FDA notified Barr Laboratories, which manufactures Plan B, that its application for over-the-counter status was denied, citing concerns about adolescent use. However, studies show that EC is safe for younger women and that they use EC responsibly. Studies also show that access to EC does not increase or encourage sexual activity among teens. The FDA was supposed to respond to a revised application from Barr allowing over-the-counter status only for women over 16 by January 26, 2005, but has not done so.

Emergency contraception pills contain hormones that reduce the risk of pregnancy when started within 120 hours of unprotected intercourse. The sooner EC is administered the better it works, making timely access critically important. Studies show that women do not rely on emergency contraception as a regular method of birth control. Research also indicates that widespread availability of EC could prevent 1.7 million unintended pregnancies and 800,000 abortions each year in the U.S.

Source

Planned Parenthood Federation of America

Contact

Erin Kiernon (202) 973-4975

Published

May 12, 2014

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of required cookies when utilizing our site; this includes necessary cookies that help our site to function (such as remembering your cookie preference settings). For more information, please see our Privacy Notice.

Marketing

On

We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.

Performance

On

We use qualitative data, including session replay, to learn about your user experience and improve our products and services.

Analytics

On

We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.